<DOC>
	<DOCNO>NCT00755716</DOCNO>
	<brief_summary>Specific aim : 1 . To obtain pilot data 4-week continuous quit rate associate 10 week treatment topiramate placebo topiramate plus nicotine patch smoking cessation . 2 . To obtain pilot data effect 10 week topiramate versus placebo versus combination topiramate plus nicotine patch nicotine withdrawal symptom , smoke satisfaction , adverse effect smoke cessation . 3 . To obtain pilot data weight gain 10 week topiramate versus placebo versus combination topiramate plus nicotine patch smoking cessation .</brief_summary>
	<brief_title>Topiramate Alone Combination With Nicotine Patch Smoking Cessation : A Pilot Study</brief_title>
	<detailed_description>This 10-week , randomize , double-blind , single-site study treatment either : topiramate , placebo , topiramate plus nicotine patch . Approximately , 90 subject age 18-65 smoke least 10 cigarette per day screen study participation , intention 60 subject eligible randomize treatment ( 20 per arm ) .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Male female cigarette smoker age 18 65 year inclusive relatively healthy . Subjects must smoke average least 10 cigarette per day past year month prior screen visit , period abstinence great 3 month past year . BMI &gt; 18kg/in2 . Subjects must free serious unstable disease within past 6 month Female subject must ) postmenopausal least two year , practice effective method birth control ( e.g. , surgically sterile , prescription oral contraceptive , contraceptive injection , intrauterine device , spermicide barrier , contraceptive patch , contraceptive ring , male partner sterilization , abstinence agree continue abstinence use acceptable method contraception , list , sexual activity commence ) entry throughout study ; negative urine pregnancy test screen visit . b ) agree avoid pregnancy 30 day last dose study medication , c ) negative urine pregnancy test ( Î²hCG ) screening baseline agree use least one birth control method note protocol . Subjects must able see outpatient , assess clinic setting , able willing comply study visit . Subjects must able provide write consent . Subjects must member household participate study . Exclusion criterion : Subjects currently suffer depression diagnose depression treat antidepressant within past 12 month . Subjects past present history psychosis , panic disorder , bipolar disorder . Subjects severe chronic obstructive pulmonary disease ( COPD ) .4 . Subjects clinically significant cardiovascular disease past 6 month Subjects clinically significant cardiovascular disease past 6 month include : myocardial infarction , coronary artery bypass graft CABG ) , percutaneous transluminal coronary angioplasty ( PTCA ) , severe unstable angina , serious arrhythmia , clinically significant ECG conduction abnormality . Subjects uncontrolled hypertension systolic blood pressure great 150 mm Hg diastolic blood pressure great 95 mm Hg screen baseline . Subjects history clinically significant neurological disorder include subject seizure disorder , cerebrovascular disease stroke transient ischemic attack ) and/or progressive degenerative neurological disorder ( e.g. , multiple sclerosis ) past 6 month . Subjects history clinically significant endocrine disorder gastrointestinal disease , include insulin dependent diabetes , uncontrolled hyperthyroidism , active peptic ulcer . Subjects clinically significant hepatic renal impairment ( e.g. , estimate creatinine clearance &lt; 60 mL/min ) . Subjects SGOT ( AST ) SGPT ( ALT ) concentration great 1.5 time upper limit normal . Subjects history cancer . Subjects believe medically unstable and/or appropriate study participation opinion principal investigator . Subjects previously treat topiramate reason discontinue treatment due adverse event due hypersensitivity reaction topiramate . Subjects evidence history clinically significant allergic reaction . Subjects allergy adhesive tape skin disorder may exacerbate nicotine patch . Subjects history drug ( except nicotine ) alcohol abuse dependence within past 12 month . Subjects positive urine drug screen . Subjects enrol study include topiramate . Subjects take plan take another investigational drug within 30 day 5 halflives ( whichever longer ) Baseline visit within 30 day study completion . Subjects take plan take concomitant medication prohibit protocol . Subjects require medication study might interfere evaluation study drug ( example , nicotine replacement therapy bupropion ) . Subjects use nicotine replacement product , bupropion , clonidine , nortriptyline within past 6 month , participate study experimental drug smoking cessation within past one year . Subjects intend use noncigarette tobacco product ( include , example , pipe tobacco , cigar , snuff , chew tobacco , etc . ) marijuana study participation . Subjects intend donate blood blood component receive study drug within 1 month completion study treatment . Subjects unable and/or unlikely comprehend follow study protocol , include ) subject , investigator 's opinion , unlikely commit duration study , b ) subject , investigator 's opinion enrol study precaution , warning contraindication outline topiramate package insert . Subjects lactose intolerance . Subjects history glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>nicotine patch</keyword>
	<keyword>smoking</keyword>
	<keyword>topiramate</keyword>
</DOC>